Pharmacoeconomic Impact of Different Regimens to Prevent Cytomegalovirus Infection in Renal Transplant Recipients

Publisher： Karger

E-ISSN： 1423-0143|35|6|407-416

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.35, Iss.6, 2012-05, pp. : 407-416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Leflunomide in Renal Transplant Recipients with Ganciclovir-Resistant/Refractory Cytomegalovirus Infection: A Case Series from the University of Chicago

By  

Case Reports in Nephrology and Dialysis, Vol. 5, Iss. 1, 2015-04 ,pp. : 96-105

Karger

Access to resources Recommend Favorite

Cytomegalovirus Infection in a Seroendemic Renal Transplant Population: A Longitudinal Study of Virological Markers

By  

Nephron, Vol. 84, Iss. 4, 2000-03 ,pp. : 367-373

Karger

Access to resources Recommend Favorite

Varicella Zoster Infection in Renal Transplant Recipients: Prevalence, Complications and Outcome

By  

Kidney and Blood Pressure Research, Vol. 34, Iss. 6, 2011-06 ,pp. : 382-386

Karger

Access to resources Recommend Favorite

Prospective Comparison of Valacyclovir and Oral Ganciclovir for Prevention of Cytomegalovirus Disease in High-Risk Renal Transplant Recipients

By  

Kidney and Blood Pressure Research, Vol. 28, Iss. 4, 2005-12 ,pp. : 218-225

Karger

Access to resources Recommend Favorite

Successful Treatment of Massive Lower Gastrointestinal Bleeding Caused by Mixed Infection of Cytomegalovirus and Mucormycosis in a Renal Transplant Recipient

By  

American Journal of Nephrology, Vol. 21, Iss. 3, 2001-06 ,pp. : 232-236

Karger

Access to resources Recommend Favorite